RxDoctor Payments Data

Shawn Moore, DO

Family Medicine · New Palestine, INNPI 1861920977

Payments from drug & device makers

$234in general payments, 2019–2025

Across 17 payments — averaging $13.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$69
  • AstraZeneca$47
  • GSK$37
  • Pfizer$23
  • Sanofi Pasteur Inc.$21
  • Exact Sciences$20
  • plus $18 from 1 others

What the payments were for

  • Food & beverage$234100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$234 in reported general payments places this provider in the 35th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$94,798
Medicare patients
172
Services billed
1,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide87$116,567
TrulicityDulaglutide28$40,332
OzempicSemaglutide24$36,829
JardianceEmpagliflozin24$36,183
EliquisApixaban34$35,738
RybelsusSemaglutide15$30,303
FarxigaDapagliflozin Propanediol18$25,433
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$12,433
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$11,123
Tresiba Flextouch U-100Insulin Degludec17$7,861
RestasisCyclosporine11$6,989
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,740
Spiriva RespimatTiotropium Bromide11$5,656
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,350
Levemir FlexpenInsulin Detemir18$3,006

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$18$67,13239 claims
Boehringer IngelheimJardiance, Spiriva Respimat$69$41,83935 claims
PfizerEliquis$23$35,73834 claims
AstraZenecaFarxiga$47$25,43318 claims
GSKTrelegy Ellipta, Shingrix$37$10,08926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in New Palestine

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →